Preparation method of citric acid toremifene intermediates

A technology of toremifene citrate and its intermediates, which is applied in the field of medicine and chemical industry, and can solve the problem of inability to prepare toremifene citrate intermediates, non-conservation of valence states, and inability to prepare toremifene citrate Intermediates and other problems, to avoid self-condensation reaction, short reaction time, and cost reduction

Active Publication Date: 2017-07-21
NINGBO TEAM PHARMA
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Deduced theoretically, because the valence state is not conserved before and after the reaction of this method, this method can not prepare toremifene citrate intermediate; and verified by actual experiments, this method can not prepare toremifene citrate intermediate 1,2-diphenyl-1-[4-[2-(N,N-dimethylamino)ethoxy]phenyl]-1,4-butanediol

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of citric acid toremifene intermediates
  • Preparation method of citric acid toremifene intermediates
  • Preparation method of citric acid toremifene intermediates

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] In a 10L three-necked flask equipped with mechanical stirring, add 400 g of 4-hydroxybenzophenone, 696 g of potassium carbonate, 5.4 kg of toluene, and 140 g of 95% industrial ethanol, and stir at 53-58° C. for 1 hour.

[0032] After cooling to below 40°C, 436 g of N,N-dimethylaminochloroethane hydrochloride was added, and the temperature was raised to 80-85°C to react for 4 hours.

[0033] Cool to below 40°C, add 2.4kg of drinking water, stir, separate layers, and discard the lower aqueous phase.

[0034] The oil phase was washed three times with 4.6 liters of 4% sodium hydroxide solution, and the 4-hydroxybenzophenone disappeared as detected by TLC; and then washed twice with 2 liters of drinking water until the pH was 8.

[0035] The obtained product was distilled off the solvent under reduced pressure at 55-60°C to obtain 521 g of a light yellow oil, and after cooling, a light yellow solid was obtained, namely 4-[2-(N,N-dimethylamino)ethoxy]diphenyl Methanone; the yi...

Embodiment 2

[0040] Throw 1.2kg of tetrahydrofuran and 54g of tetrahydrofuran into a 5L three-necked bottle, and control the temperature at 20-28°C. Slowly add the tetrahydrofuran solution of cinnamaldehyde (containing 318g of cinnamaldehyde and 960g of tetrahydrofuran) dropwise. Stir for 45 minutes. Then add the tetrahydrofuran solution of 4-[2-(N,N-dimethylamino)ethoxy]benzophenone prepared in Example 1 at this temperature (containing 465g4-[2-(N,N-dimethyl amino)ethoxy]benzophenone, 1.2 kg tetrahydrofuran). After the addition is complete, stir at 38-43°C for 1 hour.

[0041] Transfer the reaction solution to a 20-liter glass reactor, add 7 L of tetrahydrofuran, slowly add 132 g of 20% sodium hydroxide solution dropwise, stir for 10 minutes, add 960 g of anhydrous sodium sulfate, and then add dropwise of 132 g of drinking water. Stir for half an hour and filter with suction. The filter cake was washed with 1 L of tetrahydrofuran. Evaporate tetrahydrofuran under reduced pressure, add ...

Embodiment 3

[0052] Put 1080kg of toluene, 28kg of 95% industrial ethanol, 140kg of potassium carbonate and 80kg of 4-hydroxybenzophenone into a 2000L glass-lined reactor, and stir for 1 hour at 53-58°C.

[0053] The temperature was lowered to below 40°C, and 87.5 kg of N,N-dimethylaminochloroethane hydrochloride was added under the protection of nitrogen. After the throwing was complete, the temperature was raised to 80-85°C and stirred for 4 hours.

[0054] Cool down to below 40°C, add 500kg of drinking water, stir for 15 minutes, and let stand to separate layers. The upper organic phase was washed three times with 900 kg of 4% sodium hydroxide aqueous solution until the 4-hydroxybenzophenone disappeared as detected by TLC; the obtained organic phase was washed twice with 800 kg of drinking water until the pH value was 9. Concentrate the solvent under reduced pressure until no fraction is distilled under the conditions of a vacuum degree of not lower than 0.085 MPa and an internal temper...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation method of citric acid toremifene intermediates 4-[2-(N,N-dimethylamino)ethyoxyl diphenylketone and 1,2-diphenyl-1-[4[2-[2-N,N- dimethylamino]ethoxyl]-1,4-butanediol. The preparation method of the 4-[2-(N,N-dimethylamino)ethyoxyl diphenylketone comprises the steps that 4-hydroxy diphenyl ketone, inorganic alkali, a first solvent and a second solvent are mixed and are stirred at the temperature of 53-58 DEG C for 0.8-2 hours, then cooling is performed to 40 DEG C or below, N,N-dimethylamino chloroethane hydrochloride is added, heating is performed to reach 80-85 DEG C, and stirring reaction is performed for 2-5 hours; cooling is performed to 40 DEG C or below, drinking water is added, stirring is performed to make the mixture layered, and an upper-layer oil phase is taken; the oil phase is washed with 4% sodium hydroxide solution till it is detected through TLC that the 4-hydroxy diphenyl ketone disappears, then washing is performed with drinking water till pH is 8-9; the obtained product is subjected to decompression at the temperature of 55-60 DEG C to evaporate out the solvent, and the citric acid toremifene intermediates 4-[2-(N,N-dimethylamino)ethyoxyl diphenylketone is obtained after cooling.

Description

technical field [0001] The invention relates to the field of medicine and chemical industry, in particular to a toremifene citrate intermediate 4-[2-(N,N-dimethylamino)ethoxy]benzophenone and 1,2-diphenyl - a preparation method of 1-[4-[2-(N,N-dimethylamino)ethoxy]phenyl]-1,4-butanediol. Background technique [0002] Toremifene (Toremifene) is an estrogen receptor antagonist antineoplastic drug developed by Finnish Famos Company in 1983 for the treatment of postmenopausal women with estrogen receptor positive or unknown metastatic breast cancer. Lion & Company is listed in the European Union under the trade name of Fareston. Toremifene is administered orally in the form of citrate. Toremifene is similar in structure and mechanism of action to tamoxifen, and belongs to triarylbutene anti-estrogen drugs. Studies in recent years have found that toremifene citrate is an effective drug for inhibiting Ebola virus. [0003] 4-[2-(N,N-Dimethylamino)ethoxy]benzophenone (4-(2-(dim...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C213/00C07C217/22C07C213/08C07C217/20
CPCC07C213/00C07C213/06C07C213/08C07C217/22C07C217/20
Inventor 徐骥王毅斌王陈杨赵爱霞汪伟
Owner NINGBO TEAM PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products